Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.24
+0.11 (1.35%)
At close: Nov 20, 2024, 4:00 PM
8.25
+0.01 (0.12%)
Pre-market: Nov 21, 2024, 4:32 AM EST
Aurinia Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 220.36 | 175.51 | 134.03 | 45.61 | 50.12 | 0.32 | Upgrade
|
| Revenue Growth (YoY) | 38.72% | 30.95% | 193.89% | -9.00% | 15660.38% | -31.32% | Upgrade
|
| Cost of Revenue | 51 | 63.79 | 50.65 | 52.23 | 50.33 | 52.87 | Upgrade
|
| Gross Profit | 169.36 | 111.72 | 83.38 | -6.63 | -0.21 | -52.55 | Upgrade
|
| Selling, General & Admin | 185.07 | 195.04 | 196.37 | 173.54 | 97.27 | 22.34 | Upgrade
|
| Other Operating Expenses | 3.33 | 2.48 | -1.52 | 0.57 | 6.81 | 14.92 | Upgrade
|
| Operating Expenses | 188.4 | 197.52 | 194.85 | 174.11 | 104.08 | 38.4 | Upgrade
|
| Operating Income | -19.04 | -85.79 | -111.47 | -180.74 | -104.29 | -90.94 | Upgrade
|
| Interest Expense | -5 | -2.78 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 17.55 | 17 | 5.12 | 0.53 | 1.52 | 2.7 | Upgrade
|
| Currency Exchange Gain (Loss) | -5.9 | -5.9 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -12.39 | -77.47 | -106.35 | -180.21 | -102.77 | -88.24 | Upgrade
|
| Merger & Restructuring Charges | -7.76 | - | - | - | - | - | Upgrade
|
| Pretax Income | -20.14 | -77.47 | -106.35 | -180.21 | -102.77 | -88.24 | Upgrade
|
| Income Tax Expense | 2.41 | 0.55 | 1.83 | 0.76 | -0.09 | 0.14 | Upgrade
|
| Net Income | -22.55 | -78.02 | -108.18 | -180.97 | -102.68 | -88.39 | Upgrade
|
| Net Income to Common | -22.55 | -78.02 | -108.18 | -180.97 | -102.68 | -88.39 | Upgrade
|
| Shares Outstanding (Basic) | 143 | 143 | 142 | 129 | 118 | 93 | Upgrade
|
| Shares Outstanding (Diluted) | 143 | 143 | 142 | 129 | 118 | 93 | Upgrade
|
| Shares Change (YoY) | 0.41% | 0.93% | 9.70% | 9.20% | 27.36% | 9.72% | Upgrade
|
| EPS (Basic) | -0.16 | -0.54 | -0.76 | -1.40 | -0.87 | -0.95 | Upgrade
|
| EPS (Diluted) | -0.16 | -0.54 | -0.76 | -1.40 | -0.87 | -0.95 | Upgrade
|
| Free Cash Flow | 28.29 | -34.18 | -79.82 | -158 | -75.53 | -63.67 | Upgrade
|
| Free Cash Flow Per Share | 0.20 | -0.24 | -0.56 | -1.22 | -0.64 | -0.68 | Upgrade
|
| Gross Margin | 76.86% | 63.66% | 62.21% | -14.53% | -0.42% | - | Upgrade
|
| Operating Margin | -8.64% | -48.88% | -83.17% | -396.31% | -208.09% | -28598.43% | Upgrade
|
| Profit Margin | -10.23% | -44.45% | -80.71% | -396.81% | -204.88% | -27794.03% | Upgrade
|
| Free Cash Flow Margin | 12.84% | -19.47% | -59.55% | -346.44% | -150.70% | -20022.01% | Upgrade
|
| EBITDA | 0.5 | -74.14 | -108.76 | -177.97 | -102.92 | -89.77 | Upgrade
|
| EBITDA Margin | 0.22% | -42.24% | -81.15% | - | -205.35% | - | Upgrade
|
| D&A For EBITDA | 19.53 | 11.65 | 2.71 | 2.76 | 1.37 | 1.17 | Upgrade
|
| EBIT | -19.04 | -85.79 | -111.47 | -180.74 | -104.29 | -90.94 | Upgrade
|
| EBIT Margin | -8.64% | -48.88% | -83.17% | - | -208.09% | - | Upgrade
|
| Revenue as Reported | 220.36 | 175.51 | 134.03 | 45.61 | 50.12 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.